Holding(s) in Company

RNS Number : 2602E
Microgen PLC
16 December 2009
 





16 December 2009
 
Microgen plc (the “Company”)
 
Notifiable Interests
 
The Company received the following notice on 15 December 2009 in compliance with the Disclosure and Transparency Rules from Aberforth Partners LLP


 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

  Microgen PLC


2 Reason for the notification (please tick the appropriate box or boxes):


An acquisition or disposal of voting rights

Yes 


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 


An event changing the breakdown of voting rights

 


Other (please specify):

  

 


3. Full name of person(s) subject to the notification obligation:


 Aberforth Partners LLP

4. Full name of shareholder(s) (if different from 3.):


 

Shareholder
 
 
 
Shares
1. Aberforth Smaller Companies Trust plc
 
    8,890,126
2. Aberforth UK Small Companies Fund 
 
    3,910,451
3. The Church Commissioners for England
 
    1,662,500
4. Aberforth Geared Capital & Income Trust plc
    1,902,400
1,2,4 = registered in the name of Nortrust Nominees Ltd A/c Aberfrth, 3 = The Church Commissioners for England (Chase GIS) Nominees Ltd

5. Date of the transaction and date on which the threshold is crossed or reached:


 11/12/2009

6. Date on which issuer notified:


 14/12/2009

7. Threshold(s) that is/are crossed or reached:


 19%

  

8. Notified details:

A: Voting rights attached to shares


Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the 
triggering
transaction

Resulting situation after the triggering transaction

Number
of

Shares

Number
of

V
oting
Rights

Number
of shares

Number of voting
rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 Ordinary

 17,205,077

 17,205,077

 16,365,477

 N/A

 16,365,477

 N/A

 18.83

 GB0005869531


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction


Type of financial
instrument

Expiration
date

Exercise/ 
Conversion 
Period

Number of voting
rights that may be

acquired if the

instrument is

exercised/ converted.


% of voting
rights

 N/A

 N/A

 N/A

 N/A

 N/A


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction


Type of financial
instrument

Exercise 
price

Expiration 
date

Exercise/
Conversion 

period

Number of voting 
rights instrument 
refers to

% of voting rights


 N/A

 N/A

 N/A

 N/A

 N/A

Nominal

Delta


 N/A

 N/A


Total (A+B+C)


Number of voting rights

Percentage of voting rights

 16,365,477

 18.83


In addition, Aberforth Partners LLP is interested in a further 2,668,800 shares although we do not have access to the voting rights of these shares, Aberforth Partners LLP is, therefore, interested in a total of 19,034,277 shares of the above company. This interest arises as a result of the discretionary investment management powers that we can exercise over the funds of our clients. Aberforth  Partners LLP is not the beneficial owner of these shares

 

 

Proxy Voting:


10. Name of the proxy holder:


 N/A

11. Number of voting rights proxy holder will cease to hold:


 N/A

12. Date on which proxy holder will cease to hold voting rights:


 N/A


13. Additional information:


 N/A

14. Contact name:


 Pauline Robson, Aberforth Partners LLP

15. Contact telephone number:


 0131 220 0733


 

If you require further information please contact:

A. Siddiqi, Company Secretary                                  Tel: 01252 772 326

www.microgen.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFFIFWMSUSEEE
UK 100